| Year |
Citation |
Score |
| 2010 |
Hibler EA, Jurutka PW, Egan JB, Hu C, LeRoy EC, Martinez ME, Thompson PA, Jacobs ET. Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites. The Journal of Steroid Biochemistry and Molecular Biology. 121: 438-41. PMID 20307661 DOI: 10.1016/J.Jsbmb.2010.03.052 |
0.509 |
|
| 2010 |
Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, Bartik L, Egan JB, Wu Y, Kubicek JL, Lowmiller CL, Moffet EW, Forster RE, Jurutka PW. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. The Journal of Steroid Biochemistry and Molecular Biology. 121: 88-97. PMID 20227497 DOI: 10.1016/J.Jsbmb.2010.03.019 |
0.318 |
|
| 2010 |
Egan JB, Thompson PA, Ashbeck EL, Conti DV, Duggan D, Hibler E, Jurutka PW, Leroy EC, MartÃnez ME, Mount D, Jacobs ET. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Research. 70: 1496-504. PMID 20145122 DOI: 10.1158/0008-5472.Can-09-3264 |
0.536 |
|
| 2010 |
Egan JB, Thompson PA, Vitanov MV, Bartik L, Jacobs ET, Haussler MR, Gerner EW, Jurutka PW. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Molecular Carcinogenesis. 49: 337-52. PMID 20043299 DOI: 10.1002/Mc.20603 |
0.473 |
|
| 2008 |
Egan JB, Jacobs ET, MartÃnez ME, Gerner EW, Jurutka PW, Thompson PA. Presence of a TA haplotype in the APC gene containing the common 1822 polymorphism and colorectal adenoma. Cancer Research. 68: 6006-13. PMID 18632657 DOI: 10.1158/0008-5472.Can-08-1084 |
0.494 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1993 |
Lamont I, Richardson H, Carter DR, Egan JB. Genes for the establishment and maintenance of lysogeny by the temperate coliphage 186 Journal of Bacteriology. 175: 5286-5288. PMID 8349570 |
0.235 |
|
| 1986 |
Kalionis B, Dodd IB, Egan JB. Control of gene expression in the P2-related template coliphages. III. DNA sequence of the major control region of phage 186 Journal of Molecular Biology. 191: 199-209. PMID 3806670 DOI: 10.1016/0022-2836(86)90257-3 |
0.235 |
|
| 1995 |
Xue Q, Egan JB. Tail sheath and tail tube genes of the temperate coliphage 186 Virology. 212: 218-221. PMID 7676633 DOI: 10.1006/viro.1995.1471 |
0.233 |
|
| 1982 |
Hocking SM, Egan JB. Genetic studies of coliphage 186. I. Genes associated with phage morphogenesis Journal of Virology. 44: 1056-1067. PMID 6757460 |
0.233 |
|
| 2005 |
Dodd IB, Shearwin KE, Egan JB. Revisited gene regulation in bacteriophage λ Current Opinion in Genetics and Development. 15: 145-152. PMID 15797197 DOI: 10.1016/J.Gde.2005.02.001 |
0.224 |
|
| 1998 |
Portelli R, Dodd IB, Xue Q, Egan JB. The late-expressed region of the temperature coliphage 186 genome Virology. 248: 117-130. PMID 9705261 DOI: 10.1006/viro.1998.9263 |
0.224 |
|
| 2020 |
Chandrashekar P, Ahmadinejad N, Wang J, Sekulic A, Egan JB, Asmann YW, Kumar S, Maley C, Liu L. Somatic selection distinguishes oncogenes and tumor suppressor genes. Bioinformatics (Oxford, England). 36: 1712-1717. PMID 32176769 DOI: 10.1093/Bioinformatics/Btz851 |
0.223 |
|
| 1986 |
Kalionis B, Pritchard M, Egan JB. Control of gene expression in the P2-related temperate coliphages. IV. Concerning the late control gene and control of its transcription Journal of Molecular Biology. 191: 211-220. PMID 3806671 DOI: 10.1016/0022-2836(86)90258-5 |
0.223 |
|
| 1982 |
Hocking SM, Egan JB. Genetic map of coliphage 186 from a novel use of marker rescue frequencies Mgg Molecular & General Genetics. 187: 87-95. PMID 6962313 DOI: 10.1007/BF00384388 |
0.22 |
|
| 1990 |
Sivaprasad AV, Jarvinen R, Puspurs A, Egan JB. DNA replication studies with coliphage 186. III. A single phage gene is required for phage 186 replication Journal of Molecular Biology. 213: 449-463. PMID 2352277 DOI: 10.1016/S0022-2836(05)80207-4 |
0.216 |
|
| 2015 |
Kortüm KM, Langer C, Monge J, Bruins L, Zhu YX, Shi CX, Jedlowski P, Egan JB, Ojha J, Bullinger L, Kull M, Ahmann G, Rasche L, Knop S, Fonseca R, et al. Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P). Annals of Hematology. 94: 1205-11. PMID 25743686 DOI: 10.1007/s00277-015-2344-9 |
0.216 |
|
| 1968 |
Morse ML, Hill KL, Egan JB, Hengstenberg W. Metabolism of lactose by Staphylococcus aureus and its genetic basis. Journal of Bacteriology. 95: 2270-4. PMID 5669899 |
0.213 |
|
| 1975 |
Kretschmer PJ, Egan JB. Genetic map of the staphylococcal bacteriophage phi11 Journal of Virology. 16: 642-651. PMID 125802 |
0.208 |
|
| 2020 |
Zong N, Sharma DK, Yu Y, Egan JB, Davila JI, Wang C, Jiang G. Developing a FHIR-based Framework for Phenome Wide Association Studies: A Case Study with A Pan-Cancer Cohort. Amia Joint Summits On Translational Science Proceedings. Amia Joint Summits On Translational Science. 2020: 750-759. PMID 32477698 |
0.2 |
|
| 2023 |
Budhraja KK, McDonald BR, Stephens MD, Contente-Cuomo T, Markus H, Farooq M, Favaro PF, Connor S, Byron SA, Egan JB, Ernst B, McDaniel TK, Sekulic A, Tran NL, Prados MD, et al. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science Translational Medicine. 15: eabm6863. PMID 36630480 DOI: 10.1126/scitranslmed.abm6863 |
0.195 |
|
| 1989 |
Richardson H, Puspurs A, Egan JB. Control of gene expression in the P2-related temperate coliphage 186. VI. Sequence analysis of the early lytic region Journal of Molecular Biology. 206: 251-255. PMID 2704042 DOI: 10.1016/0022-2836(89)90539-1 |
0.195 |
|
| 1998 |
Shearwin KE, Brumby AM, Egan JB. The tum protein of coliphage 186 is an antirepressor Journal of Biological Chemistry. 273: 5708-5715. PMID 9488703 DOI: 10.1074/jbc.273.10.5708 |
0.194 |
|
| 1984 |
Raftery LA, Egan JB, Cline SW, Yarus M. Defined set of cloned termination suppressors: in vivo activity of isogenetic UAG, UAA, and UGA suppressor tRNAs. Journal of Bacteriology. 158: 849-59. PMID 6327642 DOI: 10.1128/Jb.158.3.849-859.1984 |
0.187 |
|
| 2014 |
Bryce AH, Borad MJ, Condjella RM, Egan JB, Champion MD, Hunt KS, McWilliams RR, McCullough AE, Kurdoglu A, Aldrich J, Izatt T, Nasser S, Christoforides A, Phillips L, Liang WS, et al. A study of real-time CLIA-enabled whole genome tumor sequencing: Results for testicular cancer and sarcomatoid RCC. Journal of Clinical Oncology. 32: 463-463. DOI: 10.1200/Jco.2014.32.4_Suppl.463 |
0.187 |
|
| 2014 |
Egan JB, Bryce AH, Champion MD, Liang WS, Fonseca R, McCullough AE, Barrett MT, Hunt K, Condjella RM, McWilliams RR, Mastrian SD, LoBello J, Hoff DV, Craig DW, Stewart AK, et al. Abstract 4694: Indices of actionability and clinical utility in a CLIA-enabled study of whole genome/exome/RNA sequencing in 33 cancer patients: Actionable vs. utility Cancer Research. 74: 4694-4694. DOI: 10.1158/1538-7445.Am2014-4694 |
0.186 |
|
| 1992 |
Dibbens JA, Gregory SL, Egan JB. Control of gene expression in the temperate coliphage 186. X. The cl repressor directly represses transcription of the late control gene B Molecular Microbiology. 6: 2643-2650. PMID 1447973 |
0.181 |
|
| 2012 |
Braggio E, O'Neill BP, Egan J, Valdez R, McPhail E, Lopes M, Schiff D, Tibes R, Stewart K, Fonseca R. Genome-Wide Analysis Uncovers Recurrent Alterations in Primary Central Nervous System Lymphomas Blood. 120: 420-420. DOI: 10.1182/BLOOD.V120.21.420.420 |
0.176 |
|
| 2002 |
Dodd IB, Egan JB. Action at a distance in CI repressor regulation of the bacteriophage 186 genetic switch Molecular Microbiology. 45: 697-710. PMID 12139616 DOI: 10.1046/j.1365-2958.2002.03038.x |
0.175 |
|
| 1990 |
Dodd IB, Kalionis B, Egan JB. Control of gene expression in the temperate coliphage 186. VIII. Control of lysis and lysogeny by a transcriptional switch involving face-to-face promoters Journal of Molecular Biology. 214: 27-37. PMID 2370665 DOI: 10.1016/0022-2836(90)90144-B |
0.174 |
|
| 2014 |
Egan JB, Barrett MT, Champion MD, Middha S, Lenkiewicz E, Evers L, Francis P, Schmidt J, Shi CX, Van Wier S, Badar S, Ahmann G, Kortuem KM, Boczek NJ, Fonseca R, et al. Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. Plos One. 9: e87113. PMID 24505276 DOI: 10.1371/Journal.Pone.0087113 |
0.174 |
|
| 2004 |
Dodd IB, Shearwin KE, Perkins AJ, Burr T, Hochschild A, Egan JB. Cooperativity in long-range gene regulation by the λ CI repressor Genes and Development. 18: 344-354. PMID 14871931 DOI: 10.1101/Gad.1167904 |
0.174 |
|
| 2009 |
Egan J, Keats JJ, Bergsagel PL, Tiedemann RE, Carpten J, Stewart AK. Comparative Genomic Hybridization, Gene Expression Profiling and Whole Genome Sequencing Analysis of Disease Progression in Myeloma Reveals Vigorous Clonal Evolution in Patients with High Baseline Genetic Risk. Blood. 114: 2810-2810. DOI: 10.1182/BLOOD.V114.22.2810.2810 |
0.173 |
|
| 2014 |
Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, Patel MD, Young SW, Collins JM, Silva AC, Condjella RM, Block M, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. Plos Genetics. 10: e1004135. PMID 24550739 DOI: 10.1371/Journal.Pgen.1004135 |
0.172 |
|
| 2007 |
Schubert RA, Dodd IB, Egan JB, Shearwin KE. Cro's role in the CI Cro bistable switch is critical for {lambda}'s transition from lysogeny to lytic development. Genes & Development. 21: 2461-72. PMID 17908932 DOI: 10.1101/Gad.1584907 |
0.172 |
|
| 1996 |
Brumby AM, Lamont I, Dodd IB, Egan JB. Defining the SOS operon of coliphage 186 Virology. 219: 105-114. PMID 8623519 DOI: 10.1006/viro.1996.0227 |
0.171 |
|
| 1989 |
Richardson H, Egan JB. DNA replication studies with coliphage 186. II. Depression of host replication by a 186 gene Journal of Molecular Biology. 206: 59-68. PMID 2704043 DOI: 10.1016/0022-2836(89)90523-8 |
0.161 |
|
| 2013 |
Braggio E, O'Neill BP, Van Wier S, Ojha J, ayres-Silva J, Valdez R, Egan J, McPhail E, Lopes MB, Schiff D, Tibes R, Stewart K, Fonseca R. The Genomic Landscape Of Primary Central Nervous System Lymphomas Blood. 122: 504-504. DOI: 10.1182/BLOOD.V122.21.504.504 |
0.161 |
|
| 1985 |
Pritchard M, Egan JB. Control of gene expression in P2-related coliphages: the in vitro transcription pattern of coliphage 186. The Embo Journal. 4: 3599-3604. PMID 3912173 |
0.16 |
|
| 2012 |
Egan J, Kortuem KM, Shi C, Schmidt J, Craig D, Carpten J, Stewart K. The Myeloma Genome in Drug Refractory Extra-Medullary Disease Identifies Mutations in Proteasome, Cereblon and Glucocorticoid Pathways Blood. 120: 3968-3968. DOI: 10.1182/blood.v120.21.3968.3968 |
0.159 |
|
| 1992 |
Dibbens JA, Egan JB. Control of gene expression in the temperate coliphage 186. IX. B is the sole phage function needed to activate transcription of the phage late genes Molecular Microbiology. 6: 2629-2642. PMID 1447972 |
0.157 |
|
| 1981 |
Finnegan J, Egan JB. In vivo transcription studies of coliphage 186 Journal of Virology. 38: 987-995. PMID 6165842 |
0.156 |
|
| 2018 |
Farooq M, Egan JB, McDonald B, Markus H, Contente-Cuomo T, Fernandez-Zapico M, Vasmatzis G, Braggio E, Borad MJ, Murtaza M. Detection of copy number aberrations in cholangiocarcinoma using shallow whole genome sequencing of plasma DNA. Journal of Clinical Oncology. 36: 293-293. DOI: 10.1200/Jco.2018.36.4_Suppl.293 |
0.155 |
|
| 1982 |
Hocking SM, Egan JB. Genetic studies of coliphage 186. II. Genes associated with phage replication and host cell lysis Journal of Virology. 44: 1068-1071. PMID 6757461 |
0.155 |
|
| 1988 |
Lamont I, Kalionis B, Egan JB. Control of gene expression in the P2-related temperate coliphages. V. The use of sequence analysis of 186 vir mutants to indicate presumptive repressor binding sites Journal of Molecular Biology. 199: 379-382. PMID 3351929 DOI: 10.1016/0022-2836(88)90321-X |
0.154 |
|
| 2001 |
Neufing PJ, Shearwin KE, Egan JB. Establishing lysogenic transcription in the temperate coliphage 186 Journal of Bacteriology. 183: 2376-2379. PMID 11244081 DOI: 10.1128/JB.183.7.2376-2379.2001 |
0.15 |
|
| 2015 |
Braggio E, Van Wier S, Ojha J, McPhail E, Asmann YW, Egan J, da Silva JA, Schiff D, Lopes MB, Decker PA, Valdez R, Tibes R, Eckloff B, Witzig TE, Stewart AK, et al. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3986-94. PMID 25991819 DOI: 10.1158/1078-0432.Ccr-14-2116 |
0.149 |
|
| 1972 |
Woods WH, Egan JB. Integration stie of noninducible coliphage 186. Journal of Bacteriology. 111: 303-7. PMID 4559723 |
0.148 |
|
| 2013 |
Schmidt J, Braggio E, Kortuem KM, Egan JB, Zhu YX, Xin CS, Tiedemann RE, Palmer SE, Garbitt VM, McCauley D, Kauffman M, Shacham S, Chesi M, Bergsagel PL, Stewart AK. Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276. Leukemia. 27: 2357-65. PMID 23752175 DOI: 10.1038/leu.2013.172 |
0.148 |
|
| 1996 |
Neufing PJ, Shearwin KE, Camerotto J, Egan JB. The CII protein of bacteriophage 186 establishes lysogeny by activating a promoter upstream of the lysogenic promoter Molecular Microbiology. 21: 751-761. PMID 8878038 DOI: 10.1046/J.1365-2958.1996.351394.X |
0.146 |
|
| 1966 |
Hogness DS, Doerfler W, Egan JB, Black LW. The position and orientation of genes in lambda and lambda dg DNA. Cold Spring Harbor Symposia On Quantitative Biology. 31: 129-38. PMID 4866370 DOI: 10.1101/Sqb.1966.031.01.020 |
0.145 |
|
| 2013 |
Borad MJ, Egan J, Champion M, Hunt K, McWilliams R, McCullough A, Aldrich J, Nasser S, Liang W, Barrett M, Craig D, Ramanathan R, Carpten J, Stewart AK, Bryce A. Abstract CT112: Implementation of CLIA enabled integrated whole genome (WGS)/exome (WES)/transcriptome (RNAseq) next-gen sequencing to identify therapeutically relevant targets in advanced cancer patients Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C66 |
0.143 |
|
| 2009 |
Palmer AC, Ahlgren-Berg A, Egan JB, Dodd IB, Shearwin KE. Potent transcriptional interference by pausing of RNA polymerases over a downstream promoter. Molecular Cell. 34: 545-55. PMID 19524535 DOI: 10.1016/J.Molcel.2009.04.018 |
0.141 |
|
| 2012 |
Liang WS, Craig DW, Carpten J, Borad MJ, Demeure MJ, Weiss GJ, Izatt T, Sinari S, Christoforides A, Aldrich J, Kurdoglu A, Barrett M, Phillips L, Benson H, Tembe W, ... ... Egan JB, et al. Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing. Plos One. 7: e43192. PMID 23071490 DOI: 10.1371/Journal.Pone.0043192 |
0.141 |
|
| 2015 |
Kortüm KM, Langer C, Monge J, Bruins L, Egan JB, Zhu YX, Shi CX, Jedlowski P, Schmidt J, Ojha J, Bullinger L, Liebisch P, Kull M, Champion MD, Van Wier S, et al. Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease. British Journal of Haematology. 168: 507-10. PMID 25302557 DOI: 10.1111/bjh.13171 |
0.139 |
|
| 2016 |
Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, Ritacca NR, McCullough AE, Barrett MT, Hunt KS, Champion MD, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, et al. Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers. Scientific Reports. 6: 25. PMID 28003660 DOI: 10.1038/S41598-016-0021-4 |
0.139 |
|
| 1994 |
Williams SG, Egan JB. DNA replication studies with coliphage 186: The involvement of the Escherichia coli DnaA protein in 186 replication is indirect Journal of Bacteriology. 176: 6039-6044. PMID 7928964 |
0.139 |
|
| 2014 |
Patrick O'Neill B, Braggio E, O'Neill BP, Van Wier S, Ojha J, McPhail E, Asmann Y, Egan J, Ayres da Silva J, Schiff D, Lopes MB, Valdez R, Tibes R, Eckloff B, Stewart AK, et al. GENOME-WIDE ANALYSIS UNCOVERS RECURRENT ALTERATIONS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS (PCNSL) Neuro-Oncology. 16: iii43-iii43. DOI: 10.1093/Neuonc/Nou209.7 |
0.137 |
|
| 1993 |
Dodd IB, Reed MR, Egan JB. The Cro-like Apl repressor of coliphage 186 is required for prophage excision and binds near the phage attachment site Molecular Microbiology. 10: 1139-1150. PMID 7934863 |
0.137 |
|
| 2021 |
Velez MG, Kosiorek HE, Egan JB, McNatty AL, Riaz IB, Hwang SR, Stewart GA, Ho TH, Moore CN, Singh P, Sharpsten RK, Costello BA, Bryce AH. Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 34294873 DOI: 10.1038/s41391-021-00430-4 |
0.136 |
|
| 2013 |
Braggio E, Egan JB, Fonseca R, Stewart AK. Lessons from next-generation sequencing analysis in hematological malignancies. Blood Cancer Journal. 3: e127. PMID 23872706 DOI: 10.1038/bcj.2013.26 |
0.136 |
|
| 2012 |
Schmidt J, Braggio E, Chesi M, Egan J, Zhu YX, Shi C, Palmer S, Garbitt V, McCauley D, Shacham S, Kauffman M, Bergsagel L, Stewart K. Genome Wide Studies in Multiple Myeloma Identify XPO1/CRM-1 As a Critical Target Validated Using the Selective Inhibitor of Nuclear Export (SINE) KPT-276 Blood. 120: 573-573. DOI: 10.1182/BLOOD.V120.21.573.573 |
0.135 |
|
| 1995 |
Xue Q, Egan JB. DNA sequence of tail fiber genes of coliphage 186 and evidence for a common ancestor shared by dsDNA phage fiber genes Virology. 212: 128-133. PMID 7676622 DOI: 10.1006/viro.1995.1461 |
0.135 |
|
| 2019 |
Velez MGG, Kosiorek H, Egan J, Bryce A. Prognostic value of tumour suppression genes (TP53, PTEN, Rb) in metastatic hormone sensitive prostate cancer Annals of Oncology. 30: v344-v345. DOI: 10.1093/annonc/mdz248.035 |
0.134 |
|
| 2017 |
Bennani NN, Ansell SM, Witzig TE, Feldman AL, McAllister TM, Lazaridis KN, Egan JB, Stewart AK, Nowakowski GS. Clinical utility of molecular testing to select therapy in relapsed/refractory non-Hodgkin lymphoma: Mayo Clinic Center for Individualized Medicine experience. Journal of Clinical Oncology. 35: 11571-11571. DOI: 10.1200/JCO.2017.35.15_SUPPL.11571 |
0.132 |
|
| 2012 |
Egan JB, Shi CX, Tembe W, Christoforides A, Kurdoglu A, Sinari S, Middha S, Asmann Y, Schmidt J, Braggio E, Keats JJ, Fonseca R, Bergsagel PL, Craig DW, Carpten JD, et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood. 120: 1060-6. PMID 22529291 DOI: 10.1182/Blood-2012-01-405977 |
0.13 |
|
| 2017 |
Yokoda R, Nagalo BM, Arora M, Egan JB, Bogenberger JM, DeLeon TT, Zhou Y, Ahn DH, Borad MJ. Oncolytic virotherapy in upper gastrointestinal tract cancers. Oncolytic Virotherapy. 7: 13-24. PMID 29616200 DOI: 10.2147/OV.S161397 |
0.129 |
|
| 2015 |
Hart SN, Moore RM, Zimmermann MT, Oliver GR, Egan JB, Bryce AH, Kocher JP. PANDA: pathway and annotation explorer for visualizing and interpreting gene-centric data. Peerj. 3: e970. PMID 26038725 DOI: 10.7717/Peerj.970 |
0.129 |
|
| 2019 |
Bryce AH, Egan JB, Smadbeck JB, Johnson SH, Murphy SJ, Harris FR, Halling GC, Terra SBSP, Cheville J, Pagliaro L, Leibovich B, Costello BA, Vasmatzis G. Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing. Scientific Reports. 9: 3586. PMID 30837548 DOI: 10.1038/S41598-019-39956-Y |
0.127 |
|
| 1972 |
Pilarski LM, Egan JB. Topology of DNA and N gene expression in coliphage lambda. Nature: New Biology. 237: 102-4 passim. PMID 4503845 DOI: 10.1038/NEWBIO237102A0 |
0.126 |
|
| 2005 |
Shearwin KE, Callen BP, Egan JB. Transcriptional interference - A crash course Trends in Genetics. 21: 339-345. PMID 15922833 DOI: 10.1016/J.Tig.2005.04.009 |
0.125 |
|
| 1989 |
Lamont I, Brumby AM, Egan JB. UV induction of coliphage 186: Prophage induction as an SOS function Proceedings of the National Academy of Sciences of the United States of America. 86: 5492-5496. PMID 2664785 |
0.124 |
|
| 1997 |
Reed MR, Shearwin KE, Pell LM, Egan JB. The dual role of Apl in prophage induction of coliphage 186 Molecular Microbiology. 23: 669-681. PMID 9157239 DOI: 10.1046/J.1365-2958.1997.2521620.X |
0.124 |
|
| 2021 |
Oliver GR, Marcano-Bonilla S, Quist J, Tolosa EJ, Iguchi E, Swanson AA, Hoppman NL, Schwab T, Sigafoos A, Prodduturi N, Voss JS, Knight SM, Zhang J, Fadra N, Urrutia R, ... ... Egan JB, et al. LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth. Plos One. 16: e0250518. PMID 34033669 DOI: 10.1371/journal.pone.0250518 |
0.122 |
|
| 1975 |
Younghusband HB, Egan JB, Inman RB. Characterization of the DNA from bacteriophage P2-186 hybrids and physical mapping of the 186 chromosome Mgg Molecular & General Genetics. 140: 101-110. PMID 1105151 DOI: 10.1007/BF00329778 |
0.122 |
|
| 2015 |
Hart SN, Moore RM, Zimmermann MT, Oliver GR, Egan JB, Bryce AH, Kocher JPA. PANDA: Pathway and annotation explorer for visualizing and interpreting gene-centric data Peerj. 2015. DOI: 10.7717/peerj.970 |
0.122 |
|
| 2005 |
Sneppen K, Dodd IB, Shearwin KE, Palmer AC, Schubert RA, Callen BP, Egan JB. A mathematical model for transcriptional interference by RNA polymerase traffic in Escherichia coli Journal of Molecular Biology. 346: 399-409. PMID 15670592 DOI: 10.1016/J.Jmb.2004.11.075 |
0.121 |
|
| 2001 |
Dodd IB, Perkins AJ, Tsemitsidis D, Egan JB. Octamerization of λ CI repressor is needed for effective repression of PRM and efficient switching from lysogeny Genes and Development. 15: 3013-3022. PMID 11711436 DOI: 10.1101/gad.937301 |
0.119 |
|
| 1997 |
Pountney DL, Tiwari RP, Egan JB. Metal- and DNA-binding properties and mutational analysis of the transcription activating factor, B, of coliphage 186: A prokaryotic C4 zinc- finger protein Protein Science. 6: 892-902. PMID 9098899 |
0.118 |
|
| 2017 |
Egan JB, Marks DL, Hogenson TL, Vrabel AM, Sigafoos AN, Tolosa EJ, Carr RM, Safgren SL, Hesles EE, Almada LL, Romecin-Duran PA, Iguchi E, Ala'Aldeen A, Kocher JA, Oliver GR, et al. Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma. Jco Precision Oncology. 2017. PMID 30761385 DOI: 10.1200/PO.17.00018 |
0.117 |
|
| 2004 |
Callen BP, Shearwin KE, Egan JB. Transcriptional interference between convergent promoters caused by elongation over the promoter Molecular Cell. 14: 647-656. PMID 15175159 DOI: 10.1016/J.Molcel.2004.05.010 |
0.114 |
|
| 2017 |
Bryce AH, Egan JB, Borad MJ, Stewart AK, Nowakowski GS, Chanan-Khan A, Patnaik MM, Ansell SM, Banck MS, Robinson SI, Mansfield AS, Klee EW, Oliver GR, McCormick JB, Huneke NE, et al. Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery. Oncotarget. 27145-27154. PMID 28423702 DOI: 10.18632/Oncotarget.16057 |
0.114 |
|
| 2006 |
Pinkett HW, Shearwin KE, Stayrook S, Dodd IB, Burr T, Hochschild A, Egan JB, Lewis M. The structural basis of cooperative regulation at an alternate genetic switch Molecular Cell. 21: 605-615. PMID 16507359 DOI: 10.1016/J.Molcel.2006.01.019 |
0.112 |
|
| 1979 |
Finnegan J, Egan JB. Physical map of the coliphage 186 chromosome - I. Gene content of the BamHI, PstI and other restriction fragments Mgg Molecular & General Genetics. 172: 287-293. PMID 45612 DOI: 10.1007/BF00271728 |
0.109 |
|
| 2000 |
Shearwin KE, Egan JB. Establishment of lysogeny in bacteriophage 186. DNA binding and transcriptional activation by the CII protein Journal of Biological Chemistry. 275: 29113-29122. PMID 10871623 DOI: 10.1074/Jbc.M004574200 |
0.107 |
|
| 1996 |
Dodd IB, Egan JB. The Escherichia coli retrons Ec67 and Ec86 replace DNA between the cos site and a transcription terminator of a 186-related prophage Virology. 219: 115-124. PMID 8623520 DOI: 10.1006/viro.1996.0228 |
0.106 |
|
| 2012 |
Keats JJ, Chesi M, Egan JB, Garbitt VM, Palmer SE, Braggio E, Van Wier S, Blackburn PR, Baker AS, Dispenzieri A, Kumar S, Rajkumar SV, Carpten JD, Barrett M, Fonseca R, et al. Clonal competition with alternating dominance in multiple myeloma. Blood. 120: 1067-76. PMID 22498740 DOI: 10.1182/Blood-2012-01-405985 |
0.106 |
|
| 2018 |
Lamberti D, Cristinziano G, Porru M, Leonetti C, Egan JB, Shi CX, Buglioni S, Amoreo CA, Castellani L, Borad MJ, Alemà S, Anastasi S, Segatto O. HSP90 inhibition drives degradation of FGFR2 fusion proteins: implications for treatment of cholangiocarcinoma. Hepatology (Baltimore, Md.). PMID 30067876 DOI: 10.1002/hep.30127 |
0.101 |
|
| 2021 |
Ledet EM, Burgess EF, Sokolova AO, Jaeger EB, Hatton W, Moses M, Miller P, Cotogno P, Layton J, Barata P, Lewis BE, Nakazawa M, Zhu J, Dellinger B, Elrefai S, ... ... Egan JB, et al. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. The Prostate. PMID 33792945 DOI: 10.1002/pros.24123 |
0.1 |
|
| 1991 |
Gille H, Egan JB, Roth A, Messer W. The FIS protein binds and bends the origin of chromosomal DNA replication, oriC, of Escherichia coli Nucleic Acids Research. 19: 4167-4172. PMID 1870971 DOI: 10.1093/Nar/19.15.4167 |
0.098 |
|
| 2020 |
Arora M, Bogenberger JM, Abdelrahman A, Leiting JL, Chen X, Egan JB, Kasimsetty A, Lenkiewicz E, Malasi S, Uson PLS, Nagalo BM, Zhou Y, Salomao MA, Kosiorek HE, Braggio E, et al. Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer. Cancer Chemotherapy and Pharmacology. PMID 32440762 DOI: 10.1007/s00280-020-04079-z |
0.098 |
|
| 2021 |
Arora M, Bogenberger JM, Abdelrahman AM, Yonkus J, Alva-Ruiz R, Leiting JL, Chen X, Serrano Uson Junior PL, Dumbauld CR, Baker AT, Gamb SI, Egan JB, Zhou Y, Nagalo BM, Meurice N, et al. Synergistic Combination of Cytotoxic Chemotherapy and Cyclin Dependent Kinase 4/6 Inhibitors in Biliary Tract Cancers. Hepatology (Baltimore, Md.). PMID 34407567 DOI: 10.1002/hep.32102 |
0.096 |
|
| 1986 |
Argos P, Landy A, Abremski K, Egan JB, Haggard-Ljungquist E, Hoess RH, Kahn ML, Kalionis B, Narayana SV, Pierson LS. The integrase family of site-specific recombinases: regional similarities and global diversity. The Embo Journal. 5: 433-440. PMID 3011407 DOI: 10.1002/J.1460-2075.1986.Tb04229.X |
0.096 |
|
| 2021 |
Farooq M, Markus H, McDonald B, Egan JB, Contente-Cuomo T, Odenheimer A, Fernandez-Zapico M, Borad MJ, Murtaza M. Detection of FGFR fusions in intrahepatic cholangiocarcinoma using targeted RNA sequencing. Journal of Clinical Oncology. 39: e16185-e16185. DOI: 10.1200/JCO.2021.39.15_SUPPL.E16185 |
0.092 |
|
| 1987 |
Dodd IB, Egan JB. Systematic method for the detection of potential λ Cro-like DNA-binding regions in proteins Journal of Molecular Biology. 194: 557-564. PMID 3625774 DOI: 10.1016/0022-2836(87)90681-4 |
0.088 |
|
| 2013 |
Egan JB, Kortuem KM, Kurdoglu A, Izatt T, Aldrich J, Reiman R, Phillips L, Baker A, Shi CX, Schmidt J, Liang WS, Craig DW, Carpten JD, Stewart AK. Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease. British Journal of Haematology. 161: 748-51. PMID 23480694 DOI: 10.1111/bjh.12291 |
0.088 |
|
| 1972 |
Egan JB, Hogness DS. The topography of lambda DNA: isolation of ordered fragments and the physical mapping of point mutations. Journal of Molecular Biology. 71: 363-81. PMID 4635989 DOI: 10.1016/0022-2836(72)90357-9 |
0.088 |
|
| 1979 |
Saint RB, Egan JB. Restriction cleavage maps of coliphages 186 and P2. Molecular & General Genetics : Mgg. 171: 79-89. PMID 286152 DOI: 10.1007/BF00274018 |
0.083 |
|
| 1982 |
Hocking SM, Egan JB. Genetic characterization of twelve P2-186 hybrid bacteriophages Mgg Molecular & General Genetics. 187: 174-176. PMID 6962312 DOI: 10.1007/BF00384403 |
0.083 |
|
| 1998 |
Coates NJ, Dibbens JA, Moffat KG, Egan JB. The use of oriC-dependent phage infection to characterize the ultra violet (UV)-induced inhibition of initiation of DNA replication in Escherichia coli Mutation Research - Dna Repair. 408: 147-157. PMID 9739817 DOI: 10.1016/S0921-8777(98)00027-5 |
0.082 |
|
| 1974 |
Woods WH, Egan JB. Prophage induction of noninducible coliphage 186 Journal of Virology. 14: 1349-1356. PMID 4610182 |
0.08 |
|
| 1982 |
Wangel AG, Milton A, Egan JB. Spontaneous plaque forming cells in the peripheral blood of patients with systemic lupus erythematosus. Clinical and Experimental Immunology. 49: 41-9. PMID 6751633 |
0.078 |
|
| 1989 |
Verma M, Moffat KG, Egan JB. UV irradiation inhibits initiation of DNA replication from oriC in Escherichia coli Mgg Molecular & General Genetics. 216: 446-454. PMID 2526290 DOI: 10.1007/BF00334389 |
0.078 |
|
| 1990 |
Dodd IB, Egan JB. Improved detection of helix-turn-helix DNA-binding motifs in protein sequences Nucleic Acids Research. 18: 5019-5026. PMID 2402433 DOI: 10.1093/nar/18.17.5019 |
0.077 |
|
| 2017 |
Yokoda R, Nagalo BM, Vernon B, Oklu R, Albadawi H, DeLeon TT, Zhou Y, Egan JB, Duda DG, Borad MJ. Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect. Oncolytic Virotherapy. 6: 39-49. PMID 29184854 DOI: 10.2147/OV.S145262 |
0.076 |
|
| 1975 |
Bradley C, Ling OP, Egan JB. Isolation of phage P2-186 intervarietal hybrids and 186 insertion mutants Mgg Molecular & General Genetics. 140: 123-135. PMID 1105153 DOI: 10.1007/BF00329780 |
0.076 |
|
| 2016 |
Bryce AH, Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, McCullough AE, Hunt KS, Ritacca NR, Barrett MT, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, et al. Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. Clinical Genitourinary Cancer. PMID 28057415 DOI: 10.1016/J.Clgc.2016.11.001 |
0.074 |
|
| 2014 |
Liang WS, Aldrich J, Nasser S, Kurdoglu A, Phillips L, Reiman R, McDonald J, Izatt T, Christoforides A, Baker A, Craig C, Egan JB, Chase DM, Farley JH, Bryce AH, et al. Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 24: 329-38. PMID 24418928 DOI: 10.1097/Igc.0000000000000049 |
0.072 |
|
| 1973 |
Pilarksi LM, Egan JB. Role of DNA topology in transcription of coliphage lambda in vivo. II. DNA topology protects the template from exonuclease attack. Journal of Molecular Biology. 76: 257-66. PMID 4579547 DOI: 10.1016/0022-2836(73)90389-6 |
0.067 |
|
| 1973 |
Kretschmer PJ, Egan JB. Isolation of a suppressor host bacterium in Staphylococcus aureus Journal of Bacteriology. 116: 84-87. PMID 4270444 |
0.057 |
|
| 1961 |
EGAN JB, HOLLOWAY BW. Genetic studies on lysogeny in Pseudomonas aeruginosa. The Australian Journal of Experimental Biology and Medical Science. 39: 9-17. PMID 13725887 |
0.056 |
|
| 2017 |
Myers CE, Hoelzinger DB, Truong TN, Chew LA, Myles A, Chaudhuri L, Egan JB, Liu J, Gendler SJ, Cohen PA. Chemotherapy can induce weight normalization of morbidly obese mice despite undiminished ingestion of high fat diet. Oncotarget. PMID 28076839 DOI: 10.18632/Oncotarget.14576 |
0.054 |
|
| 1965 |
EGAN JB, MORSE ML. CARBOHYDRATE TRANSPORT IN STAPHYLOCOCCUS AUREUS I. GENETIC AND BIOCHEMICAL ANALYSIS OF A PLEIOTROPIC TRANSPORT MUTANT. Biochimica Et Biophysica Acta. 97: 310-9. PMID 14292840 |
0.054 |
|
| 1985 |
Verma M, Egan JB. Phenotypic variations in strain AB1157 cultivars of Escherichia coli from different sources Journal of Bacteriology. 164: 1381-1382. PMID 3905771 |
0.053 |
|
| 1981 |
Hooper I, Egan JB. Coliphage 186 infection requires host initiation functions dnaA and dnaC Journal of Virology. 40: 599-601. PMID 7033562 |
0.044 |
|
| 1967 |
Hengstenberg W, Egan JB, Morse ML. Carbohydrate transport in Staphylococcus aureus. V. The accumulation of phosphorylated carbohydrate derivatives, and evidence for a new enzyme-splitting lactose phosphate. Proceedings of the National Academy of Sciences of the United States of America. 58: 274-9. PMID 4292101 |
0.031 |
|
| 2005 |
Trusina A, Sneppen K, Dodd IB, Shearwin KE, Egan JB. Functional alignment of regulatory networks: a study of temperate phages. Plos Computational Biology. 1: e74. PMID 16477325 DOI: 10.1371/Journal.Pcbi.0010074 |
0.028 |
|
| 2019 |
Arora M, Bogenberger JM, Nagalo MB, Zhou Y, Kannan L, Egan J, Yokoda RT, Ahn DH, Bekaii-Saab T, Borad M. 413 – Synergy of Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors with Cytotoxic Chemotherapy in Cholangiocarcinoma Gastroenterology. 156: S-1198. DOI: 10.1016/S0016-5085(19)39973-1 |
0.027 |
|
| 1968 |
Hengstenberg W, Egan JB, Morse ML. Carbohydrate transport in Staphylococcus aureus. VI. The nature of the derivatives accumulated. The Journal of Biological Chemistry. 243: 1881-5. PMID 4869132 |
0.026 |
|
| 1966 |
Egan JB, Morse ML. Carbohydrate transport in Staphylococcus aureus. 3. Studies of the transport process. Biochimica Et Biophysica Acta. 112: 63-73. PMID 5947899 |
0.023 |
|
| 1979 |
Buckley TF, Egan JB. Studies on chocolate agar. Part II. The importance of the method of preparation of chocolate agar plates and the effects of this on the isolation rate of Pneumococci and Haemophilus from sputum Journal of the Academy of Medical Laboratory Science. 1: 27-30. |
0.022 |
|
| 1979 |
Buckley TF, Egan JB. Studies on chocolate agar. Part I. The importance of the basal media used in chocolate agar plates and the effects of this on the efficiency of sputum culture for Haemophilus and Pneumococci Journal of the Academy of Medical Laboratory Science. 1: 21-25. |
0.021 |
|
| 1973 |
Button DK, Egan JB, Hengstenberg W, Morse ML. Carbohydrate transport in staphylococcus aureus IV. Maltose accumulation and metabolism Biochemical and Biophysical Research Communications. 52: 850-855. PMID 4710567 DOI: 10.1016/0006-291X(73)91015-2 |
0.017 |
|
| 1969 |
Lawson JS, Brand IA, Lane A, Keane WM, Yeatman JS, Egan JB. Graduate training. The availability of hospital experience for recent medical graduates in Victoria. The Medical Journal of Australia. 2: 1018-21. PMID 5373219 |
0.01 |
|
| 1960 |
HOLLOWAY BW, EGAN JB, MONK M. Lysogeny in Pseudomonas aeruginosa. The Australian Journal of Experimental Biology and Medical Science. 38: 321-9. PMID 13715401 |
0.01 |
|
| 1958 |
RUBBO SD, ROUCH LC, EGAN JB, WADDINGTON AL, TELLESSON WG. Chemotherapy of tuberculosis. III. Verazide in the treatment of pulmonary tuberculosis. American Review of Tuberculosis. 78: 251-8. PMID 13559656 |
0.01 |
|
| Hide low-probability matches. |